Bruno Tasso
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Exploring the Hydrazone Group in Multifunctional Approaches for Alzheimer's Disease Therapy.
Journal: ChemMedChem
Published: December 05, 2025
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: October 16, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.
Journal: International journal of molecular sciences
Published: April 29, 2025
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells.
Journal: Biochemical pharmacology
Published: April 22, 2025
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays.
Journal: International journal of molecular sciences
Published: September 12, 2024
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives.
Journal: Molecules (Basel, Switzerland)
Published: April 04, 2024
New Pyrazolyl Thioureas Active against the Staphylococcus Genus.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 27, 2023
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis.
Journal: Antioxidants (Basel, Switzerland)
Published: November 03, 2023
Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3.
Journal: Molecules (Basel, Switzerland)
Published: August 09, 2023
Indole Antitumor Agents in Nanotechnology Formulations: An Overview.
Journal: Pharmaceutics
Published: May 30, 2023
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells.
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: November 30, 2022
Nanotechnology for Pediatric Retinoblastoma Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 05, 2022
Last Updated: 09/26/2026